The First Affiliated Hospital of Xinjiang Medical University
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study was to compare the efficacy and safety of adrenalectomy and superselective adrenal artery embolization in a prospective, multicenter, randomized controlled study. To provide a new interventional alternative therapy for primary aldosteronism.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:
• Age 18-60
• Diagnosed with primary aldosteronism according to the 2016 Clinical guidelines of the International Endocrine Society
• Primary aldosteronism diagnosed according to international guidelines Unilateral disease by AVS or PET-CT criteria
• Patients and their family members signed informed consent and agreed to participate in the study
Locations
Other Locations
China
The First Affiliated Hospital of Xinjiang Medical University
RECRUITING
Ürümqi
Contact Information
Primary
Xiang Xie, PhD
xiangxie999@sina.com
+869914366892
Backup
Changjiang Deng
1187229853@qq.com
+869914366892
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 570
Treatments
Experimental: Superselective adrenal artery embolization group
Superselective adrenal artery embolization for primary aldosteronism
Active_comparator: Adrenalectomy group
Adrenalectomy for primary aldosteronism
Related Therapeutic Areas
Sponsors
Leads: Xinjiang Medical University
Collaborators: First Affiliated Hospital of Xinjiang Medical University